Select your timezone:

Campfire Session
Biomarkers, monitoring & outcomes

Tuesday September 13, 2022 | 17:35 to 18:35
Room: CF-5
Track: Basic and Translational Sciences


For attending this session, you can claim 1 EACCME credits


Mr. James M Halle-Smith, United Kingdom
C-reactive protein and urea levels distinguish primary non-function from early allograft dysfunction after liver transplantation

Dr. Reginald Y Gohh, United States
Delta Changes In Donor-derived Cell-free DNA (dd-cfDNA) Complement The Donor Fraction In Kidney Transplant Surveillance

Carla C. Baan, Netherlands
Extracellular Vesicles released during Normothermic Machine Perfusion are associated with human donor kidney characteristics

Miss Marina Vidal dos Santos, Brazil
Kidney release of inflammatory mediators is modulated by 17beta-estradiol associated with methylprednisolone after brain death in female rats

Mr. Sam Kavarana, United States
Reduced Epidermal Growth Factor (EGF) Expression During Antibody Mediated Rejection Following Heart Transplantation

Dr. Adela D Mattiazzi, United States
Early Post-Operative Thrombotic Microangiopathy in Deceased Donor Kidney Transplant: Case Series

Dr. Olga Gichkun, Russian Federation
The plasma level of transforming growth factor beta 1 in heart transplant recipients: relationship with HLA mismatch

Dr. Séverine Bézie, France
Clinical grade CD8+T regulatory cells moving forward in human transplantation

Ms. Leonie van Leeuwen, Netherlands
Unravelling the molecular footprint of kidney graft quality: From subjective assessment to tailored treatment

Dr. Minnie M. Sarwal, United States
QSant, a urine-based multi-analyte assay, detects and predicts acute rejection risk with high accuracy, in the first 2 weeks post-transplant

© 2024 TTS 2022